Shareholding disclosure
Dr. David E. Shaw
Declared position
4.032%
Threshold
Crossed upwards
Timeline
Published
06.03.2025
Transaction
25.02.2025
Voting rights breakdown
Notice details
Notification ID
ZA01-000000000PV14
Beneficial owner
Dr. David E. Shaw
Declared address
Dr David E. Shaw, New York, US
D. E. Shaw Valence International, Inc. has entered into a lock-up agreement with Idorsia Ltd ("Idorsia"), Idorsia Pharmaceuticals Ltd and certain holders of Idorsia convertible bonds 2025 (ISIN CH0426820350) (the "CB2025") and/or Idorsia convertible bonds 2028 (ISIN CH1128004079) (the "CB2028") dated 25 February 2025 (the "Lock-Up Agreement") and is thus a member of the lock-up group disclosed on 3 March 2025. The purchase positions included in this disclosure notification includes only the positions held by D. E. Shaw Valence International, Inc. (alongside other purchase positions held by D. E. Shaw Valence International, Inc. and D. E. Shaw Oculus International, Inc.) that are not locked under the Lock-Up Agreement and, hence, are not covered by the lock-up group disclosure. Under the Lock-Up Agreement and a backstop letter agreement with Idorsia Ltd, Idorsia Pharmaceuticals Ltd and certain holders of CB2025 and/or CB2028, dated 25 February 2025 and to which D. E. Shaw Valence Investments (Cayman) Limited is a party (the "Backstop Letter"; the Backstop Letter together with the Lock-Up Agreement, the "Agreements"), D. E. Shaw Valence International, Inc. and D. E. Shaw Valence Investments (Cayman) Limited collectively hold the rights to receive: - 3'954'369 registered shares of Idorsia (the "Shares") as per different conditions and milestone events as defined in the Agreements up until Q3/2025 as backstop fee, arrangement fee and exchange fee. 1'437'600 Shares to be received under the backstop fee have been finally allocated, but not delivered. The Shares to be received under the arrangement fee and exchange fee have been allocated as of 25 February 2025 but are subject to potential changes before final delivery, pursuant to the Agreements; - 3'634'903 warrants for Shares (with the terms as set forth below, the "Warrant") as per different conditions and milestones events as defined in the Agreements until Q3/2025 as backstop fee, arrangement fee and exchange fee. 1'277'867 Warrants to be received under the backstop fee have been finally allocated, but not delivered. The Warrants to be received under the arrangement fee and exchange fee have been allocated as of 25 February 2025 but are subject to potential changes before final delivery, pursuant to the Agreements.
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan